Regeneron registry update: new MUC16 trial added; HS, MASH, ALD, melanoma, obesity studies continueNov 12Weekly roundup, 6 itemsALN-CIDEBALN-HSDUpdated
Regeneron registers Phase 3 LINKER-AL1 trial of linvoseltamab for AL amyloidosisOct 30Weekly roundup, 6 itemscemiplimab-rwlcdupilumabUpdated
Regeneron registers two new trials: prion disease gene therapy and HS/obesity combo drugSep 22Weekly roundup, 2 itemsALN-6457olatorepatide
Regeneron's Phase 2 olatorepatide obesity trial recruiting across five U.S. sitesJul 6Trial updateolatorepatideRegeneron Pharmaceuticals